Michael J Ackerman Selected Research

Fibrosis (Cirrhosis)

1/2021	Myocardial Histopathology in Patients With Obstructive Hypertrophic Cardiomyopathy.
1/2010	Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
9/2009	Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J Ackerman Research Topics

Disease

126	Long QT Syndrome 02/2024 - 03/2002
46	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 04/2024 - 03/2002
43	Cardiac Arrhythmias (Arrythmia) 05/2024 - 08/2002
38	Cardiac Sudden Death (Sudden Cardiac Arrest) 05/2024 - 03/2002
31	Cardiovascular Diseases (Cardiovascular Disease) 07/2023 - 01/2003
30	Polymorphic catecholergic ventricular tachycardia 04/2024 - 11/2004
24	Heart Arrest (Cardiac Arrest) 02/2024 - 01/2003
24	Syncope (Fainting) 02/2024 - 01/2003
22	Sudden Infant Death (SID) 01/2020 - 06/2004
21	Channelopathies 01/2022 - 08/2002
20	Ventricular Fibrillation 01/2023 - 11/2002
19	Cardiomyopathies (Cardiomyopathy) 05/2022 - 02/2006
18	Sudden Death 01/2022 - 06/2002
17	Brugada Syndrome 01/2020 - 08/2002
15	Ventricular Tachycardia 12/2023 - 05/2002
11	Shock 02/2024 - 11/2010
11	Heart Diseases (Heart Disease) 07/2023 - 03/2002
10	Torsades de Pointes (Torsade de Pointes) 12/2023 - 01/2005
9	Atrial Fibrillation 04/2024 - 03/2008
8	Hypertrophy 01/2023 - 06/2005
8	Cardiomegaly (Heart Hypertrophy) 11/2019 - 08/2005
7	Seizures (Absence Seizure) 10/2022 - 08/2013
6	COVID-19 01/2023 - 01/2020
6	Heart Failure 03/2019 - 10/2008
6	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019 - 10/2005
5	Bradycardia 01/2019 - 07/2003
4	Ventricular Premature Complexes (Premature Ventricular Contraction) 05/2022 - 01/2013
4	Stroke (Strokes) 03/2016 - 10/2008
3	Coronary Artery Disease (Coronary Atherosclerosis) 05/2024 - 01/2016
3	Epilepsy (Aura) 05/2024 - 11/2012
3	Short Qt Syndrome 12/2022 - 08/2010
3	Acidosis 01/2022 - 05/2011
3	Infections 03/2021 - 03/2002
3	Fibrosis (Cirrhosis) 01/2021 - 09/2009
3	Inflammation (Inflammations) 01/2020 - 04/2007
3	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 04/2007
3	Transient Ischemic Attack 03/2016 - 09/2013
3	Andersen Syndrome 10/2009 - 10/2004
2	Hypertension (High Blood Pressure) 05/2024 - 01/2022
2	Nausea 12/2023 - 01/2022
2	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2022 - 01/2016
2	Postoperative Nausea and Vomiting (PONV) 01/2022 - 02/2013
2	Vascular Diseases (Vascular Disease) 01/2021 - 01/2019
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 01/2017
2	Rare Diseases (Rare Disease) 01/2020 - 11/2007
2	Congenital Heart Defects (Congenital Heart Defect) 07/2019 - 11/2018

Drug/Important Bio-Agent (IBA)

39	Proteins (Proteins, Gene)FDA Link 11/2020 - 05/2005
27	Sodium Channels (Sodium Channel)IBA 01/2023 - 08/2002
25	Ion Channels (Ion Channel)IBA 01/2022 - 01/2005
24	DNA (Deoxyribonucleic Acid)IBA 11/2014 - 03/2003
23	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 04/2024 - 10/2004
15	Potassium Channels (Potassium Channel)IBA 02/2024 - 12/2002
12	CalciumIBA 01/2023 - 06/2007
11	SodiumIBA 01/2020 - 08/2002
6	triadinIBA 01/2023 - 06/2015
6	Caveolin 3IBA 11/2020 - 11/2006
6	Ventricular MyosinsIBA 10/2020 - 06/2002
6	Epinephrine (Adrenaline)FDA LinkGeneric 10/2016 - 05/2002
5	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2020
5	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2019 - 06/2013
5	junctophilinIBA 02/2017 - 06/2007
5	Ether (Diethyl Ether)IBA 12/2012 - 12/2002
5	TropomyosinIBA 02/2011 - 12/2002
4	Troponin T (Troponin T1)IBA 01/2023 - 06/2002
4	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022 - 10/2009
4	KCNQ1 Potassium ChannelIBA 01/2022 - 03/2012
4	Azithromycin (Zithromax)FDA LinkGeneric 03/2021 - 09/2013
4	Mexiletine (Mexitil)FDA LinkGeneric 01/2019 - 08/2002
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 12/2013
4	Troponin CIBA 10/2015 - 08/2008
3	CatecholaminesIBA 01/2023 - 01/2003
3	Sodium Channel BlockersIBA 10/2022 - 01/2019
3	ElectrolytesIBA 03/2019 - 09/2011
3	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2019 - 01/2016
3	NucleotidesIBA 01/2019 - 10/2012
3	metavinculinIBA 10/2006 - 02/2006
2	MYK-461IBA 04/2024 - 02/2024
2	Flecainide (Tambocor)FDA LinkGeneric 02/2024 - 10/2023
2	Ondansetron (Zofran)FDA LinkGeneric 12/2023 - 01/2022
2	GlucocorticoidsIBA 01/2023 - 12/2018
2	SDMIBA 01/2023 - 10/2021
2	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2023 - 07/2012
2	Polyvinyl Chloride (PVC)IBA 05/2022 - 01/2013
2	Cadherins (E-Cadherin)IBA 01/2021 - 03/2017
2	Anti-Arrhythmia AgentsIBA 01/2020 - 01/2015
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020 - 11/2005
2	AutoantibodiesIBA 01/2020 - 11/2018
2	Myosin Light Chains (Myosin Essential Light Chain)IBA 10/2019 - 07/2008
2	dofetilide (Tikosyn)FDA Link 03/2019 - 01/2018
2	Troponin IIBA 01/2019 - 12/2015
2	PotassiumIBA 01/2019 - 05/2012

Therapy/Procedure

60	Therapeutics 04/2024 - 03/2004
43	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 04/2024 - 03/2002
23	Sympathectomy (Sympathectomies) 07/2023 - 06/2009
9	Defibrillators (Defibrillator) 01/2024 - 11/2002
5	Secondary Prevention 04/2013 - 03/2002
4	Precision Medicine 01/2021 - 04/2013
4	Drug Therapy (Chemotherapy) 01/2020 - 03/2008
4	Genomic Medicine 01/2017 - 05/2005
2	Catheter Ablation 01/2022 - 01/2018